We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current PKPH market cap is 31.49M. The company's latest EPS is USD -0.1421 and P/E is -10.91.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6k | -6k | -69k | -163k | -2.46M |
| Net Income | -14k | -15k | -76k | -165k | -2.89M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1,000 | 0 | 261k | 130k | 78k |
| Total Liabilities | 236k | 250k | 587k | 621k | 3.33M |
| Total Equity | -235k | -250k | -326k | -491k | -3.25M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1,000 | -1,000 | -14k | -68k | -935k |
| Investing | N/A | N/A | N/A | N/A | 10k |
| Financing | N/A | N/A | 275k | -65k | 934k |
| Market Cap | 31.49M |
| Price to Earnings Ratio | -10.91 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.88k |
| Price to Book Ratio | -9.69 |
| Dividend Yield | - |
| Shares Outstanding | 20.31M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -39.69% |
| 52 Week High | 3.00 |
| 52 Week Low | 1.37 |
| Spread (Intraday) | 1.03 (39.77%) |
| Company Name | Peak Pharmaceuticals Inc (PK) |
| Address |
14201 n. hayden road, suite a-1, scottsdale, az 85260 |
| Website | https://www.peakpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
